Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HMGCR | P04035 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | CPT2 | P23786 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7158460 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CYP2C19CYP3A4CYP2C9MEN1 | |
| SCHEMBL9246722 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CYP2C19CYP3A4CYP2C9MEN1 | |
| Dimethylamine SCHEMBL9133373 | 0.94 | ALDH1A1 (0.51) | ALDH1A1CYP2C19CYP3A4CYP2C9MEN1 | |
| Dimethylamine SCHEMBL9133610 | 0.94 | ALDH1A1 (0.51) | ALDH1A1CYP2C19CYP3A4CYP2C9MEN1 | |
| Acrylamide SCHEMBL28046099 | 0.92 | ALDH1A1 (0.50) | ALDH1A1CYP2C19CYP3A4CYP2C9MEN1 | |
| SCHEMBL17266437 | 0.85 | CYP2C19 (0.46) | ALDH1A1CYP2C19CYP3A4CYP2C9MEN1 | |
| Hydrochloric Acid SCHEMBL9133471 | 0.85 | ALDH1A1 (0.44) | ALDH1A1CYP2C19CYP3A4CYP2C9MEN1 | |
| SCHEMBL35470 | 0.83 | ALDH1A1 (0.51) | ALDH1A1CYP2C19CYP3A4CYP2C9MEN1 | |
| SCHEMBL16915525 | 0.83 | ALDH1A1 (0.51) | ALDH1A1CYP2C19CYP3A4CYP2C9MEN1 | |
| SCHEMBL19860763 | 0.82 | ALDH1A1 (0.55) | ALDH1A1CYP2C19CYP3A4CYP2C9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705526-B1 | POLYMER TANNING AGENT | SNF GROUP (FR) | 2026-05-27 | — | — | EP | claimed |
| EP-4727899-A1 | METHOD FOR DEWATERING MINE TAILINGS | SNF Group (FR) | 2026-04-22 | — | — | EP | claimed |
| EP-4705526-A1 | POLYMER TANNING AGENT | SNF Group (FR) | 2026-03-11 | — | — | EP | claimed |
| WO-2025262076-A1 | METHOD FOR RECOVERING ONE OR MORE VALUABLE COMPOUNDS BY FLOTATION | SNF GROUP (FR) | 2025-12-26 | — | — | WO | claimed |
| EP-3762433-B1 | SELF-INVERTING REVERSE LATEX, COMPRISING AS INVERTING AGENT SURFACTANT SPECIES OF THE POLYGLYCEROL ESTER FAMILY AND COMPOSITIONS COMPRISING IT | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2025-07-23 | — | — | EP | claimed |
| WO-2025082989-A1 | OLIGO-INITIATOR AND ITS USE FOR PRODUCING WATER-SOLUBLE HYBRID POLYMERS | SNF GROUP (FR) | 2025-04-24 | — | — | WO | claimed |
| US-12264219-B2 | Conductive benzoic acid based polymer containing biomaterial for enhancement of tissue conduction in vitro and in vivo | UNIVERSITY HEALTH NETWORK (CA) | 2025-04-01 | — | — | US | claimed |
| EP-3774950-B1 | AQUEOUS LIQUID DETERGENT COMPOSITION FOR HOUSEHOLD OR INDUSTRIAL USE COMPRISING A SELF-INVERTIBLE INVERSE LATEX WITH THE ACRYLAMIDE MONOMER, COMPRISING POLYGLYCEROL ESTERS, AND USE THEREOF AS THICKENING AGENT IN A DETERGENT OR CLEANING FORMULATION | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2025-03-26 | — | — | EP | claimed |
| US-12251453-B2 | Self-invertible inverse latex comprising polyglycyerol esters, use thereof as a thickening agent, and cosmetic compositions comprising same | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2025-03-18 | — | — | US | claimed |
| WO-2025040784-A1 | WATER-SOLUBLE POLYMER AS BATTERY BINDING MATERIAL | SNF GROUP (FR) | 2025-02-27 | — | — | WO | claimed |
| EP-0411711-A2 | Attachment of compounds to polymeric particles using dication ethers and a kit containing same | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1991-02-06 | — | — | EP | claimed |
| US-4915937-A | PHOSPHATASE INHIBITOR | THE BF GOODRICH COMPANY (US) | 1990-04-10 | — | — | US | claimed |
| CN-1039720-A | DENTAL ANTIHYDROLYSIS AGENT | GOODRICH CO B F (US) | 1990-02-21 | — | — | CN | claimed |
| EP-0353648-A2 | Dental antihydrolysis agent | THE B.F. GOODRICH COMPANY (US) | 1990-02-07 | — | — | EP | claimed |
| US-4784774-A | ACRYLIC COPOLYMER FOR SCALE INHIBITION | THE B. F. GOODRICH COMPANY (US) | 1988-11-15 | — | — | US | claimed |
| US-4728436-A | INDUSTRIAL COOLING WATERS | NALCO CHEMICAL COMPANY (US) | 1988-03-01 | — | — | US | claimed |
| US-4649183-A | POLYMER OF ACRYLAMIDE AND ACRYLAMIDOALKANOIC ACID OR SALT, FLOW CONTROL AGNETS, ENHANCED OIL RECOVERY | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 1987-03-10 | — | — | US | claimed |
| EP-0206489-A2 | Calcium-Tolerant N-Substituted Acrylamides as Thickeners for aqueous Systems | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 1986-12-30 | — | — | EP | claimed |
| US-4584358-A | ENHANCED OIL RECOVERY | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 1986-04-22 | — | — | US | claimed |
| US-4088499-A | METHYLENE GROUP CONTAINING POLYMERS | EASTMAN KODAK COMPANY (US) | 1978-05-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12251453-B2 | Self-invertible inverse latex comprising polyglycyerol esters, use thereof as a thickening agent, and cosmetic compositions comprising same | UGCG, DAGLA, DAGLB | ALDH1A1 1920/4885CYP2C19 3484/4885CYP3A4 4531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.